Xeris Biopharma Holdings, Inc. (XERS)

Xeris Biopharma Holdings Revenue

Xeris Biopharma Holdings had revenue of $54.27M in the quarter ending September 30, 2024, with 12.31% growth. This brings the company's revenue in the last twelve months to $187.36M, up 22.72% year-over-year. In the year 2023, Xeris Biopharma Holdings had annual revenue of $163.91M with 48.68% growth.

• Revenue (ttm): $187.36M
• Revenue Growth: +22.72%
• P/S Ratio: 2.68
• Revenue / Employee: $496,979
• Employees: 377
• Market Cap: 520.29M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	163.91M	53.67M	48.68%
Dec 31, 2022	110.25M	60.66M	122.32%
Dec 31, 2021	49.59M	29.16M	142.67%
Dec 31, 2020	20.44M	17.71M	650.73%
Dec 31, 2019	2.72M	299.00K	12.34%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.